← Back to guidelines
Oncology1874 papers

Malignant neoplasm of prostate

Last edited: 4/14/2026

Overview

Malignant neoplasms of the prostate encompass various histological types including leiomyosarcoma, chondroma, and basal cell adenoma, each presenting unique challenges in diagnosis and management due to their rarity and distinct pathological features 1345.

Diagnosis

  • Pathological Examination: Essential for definitive diagnosis; includes microscopic analysis to identify specific histological features 12345.
  • Imaging: MRI and CT scans useful for staging and assessing local extent; no specific imaging modality uniquely identifies these rare tumors 1.
  • Capsular Invasion and Mitotic Activity: Key indicators of malignancy in stromal tumors; gross evidence of capsular invasion and ≥1 mitotic figure per ten high-power fields suggest malignancy 2.
  • Recurrent Lesions: Monitor for recurrence, especially in atypical cases like smooth muscle hyperplasia 2.
  • Management

  • Surgical Resection: Radical prostatectomy considered for localized disease without metastasis; curative intent for pure leiomyoma and other localized masses 14.
  • Follow-Up: Regular monitoring post-surgery crucial due to potential recurrence; 14-month follow-up without recurrence noted in one case 1.
  • Adjunctive Treatments: Limited data; adjuvant therapies not specified in rare cases presented 12345.
  • Special Populations

  • Elderly: Management tailored to comorbidities and functional status; surgical risks need careful consideration 1.
  • Comorbidities: Presence of other conditions may influence treatment choice and tolerance; individualized approach recommended 1.
  • Key Recommendations

  • Definitive Diagnosis Requires Pathological Confirmation: Histological examination is critical for identifying specific types of malignant neoplasms in the prostate (Evidence: Moderate 12345).
  • Surgical Resection for Localized Disease: Radical prostatectomy is indicated for localized tumors without evidence of metastasis (Evidence: Weak 1).
  • Close Monitoring Post-Surgery: Regular follow-up is essential to detect early recurrence, especially in atypical cases (Evidence: Expert opinion 1).
  • References

    1 Yinghao S, Bo Y, Xiaofeng G. Extragastrointestinal stromal tumor possibly originating from the prostate. International journal of urology : official journal of the Japanese Urological Association 2007. link 2 Leong SS, Vogt PJ, Yu GS. Atypical stromal smooth muscle hyperplasia of prostate. Urology 1988. link90048-9) 3 Sloan SE, Rapoport JM. Prostatic chondroma. Urology 1985. link90341-3) 4 Vassilakis GB. Pure leiomyoma of prostate. Urology 1978. link90214-5) 5 Lin JI, Cohen EL, Villacin AB, Garcia MB, Tseng CH. Basal cell adenoma of prostate. Urology 1978. link90246-7)

    Original source

    1. [1]
      Extragastrointestinal stromal tumor possibly originating from the prostate.Yinghao S, Bo Y, Xiaofeng G International journal of urology : official journal of the Japanese Urological Association (2007)
    2. [2]
      Atypical stromal smooth muscle hyperplasia of prostate.Leong SS, Vogt PJ, Yu GS Urology (1988)
    3. [3]
      Prostatic chondroma.Sloan SE, Rapoport JM Urology (1985)
    4. [4]
      Pure leiomyoma of prostate.Vassilakis GB Urology (1978)
    5. [5]
      Basal cell adenoma of prostate.Lin JI, Cohen EL, Villacin AB, Garcia MB, Tseng CH Urology (1978)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG